AIDS Funding Increased for Fiscal '97

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 11
Volume 5
Issue 11

WASHINGTON-Federal AIDS programs faired well in the budget bill passed by Congress and signed by President Clinton, which included increased funding in fiscal year 1997 for research, prevention, care, and drug assistance.

WASHINGTON—Federal AIDS programs faired well in the budget bill passed by Congress and signed by President Clinton, which included increased funding in fiscal year 1997 for research, prevention, care, and drug assistance.

The legislation provided the Department of Health and Human Services, which funds the vast majority of AIDS projects, with $3.213 billion for its AIDS programs outside of Medicare and Medicaid. This represents a 12.4% increase over the $2.856 billion provided in fiscal 1996, according to the White House Office of National AIDS Policy.

The legislation upped funding for programs that help HIV patients purchase drugs to $167 million, an increase of 221%; increased AIDS research funding at NIH to $1.5 billion, a 6.7% increase; and provided $617 million for AIDS prevention programs, a 6% increase.

Recent Videos
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content